Omar Nass

961 total citations · 1 hit paper
10 papers, 796 citations indexed

About

Omar Nass is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Omar Nass has authored 10 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 2 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in Omar Nass's work include Cardiovascular Function and Risk Factors (6 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Cardiac Fibrosis and Remodeling (2 papers). Omar Nass is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Cardiac Fibrosis and Remodeling (2 papers). Omar Nass collaborates with scholars based in United States, United Kingdom and Israel. Omar Nass's co-authors include Hani N. Sabbah, O. A. Carretero, Edward L. Peterson, Victor G. Sharov, Xiaoping Yang, Liu Y, Xiaoping Yang, George Suzuki, Takayuki Mishima and Pervaiz A. Chaudhry and has published in prestigious journals such as Journal of Clinical Investigation, The American Journal of Cardiology and British Journal of Pharmacology.

In The Last Decade

Omar Nass

10 papers receiving 772 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

1997 513 citations Liu Y, Xiaoping Yang et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Omar Nass United States	7	680	250	177	112	75	10	796
Yasutaka Moriguchi Japan	8	459 0.7×	442 1.8×	181 1.0×	70 0.6×	62 0.8×	8	745
Yutaka Nio Japan	7	502 0.7×	328 1.3×	243 1.4×	34 0.3×	46 0.6×	11	647
Q Li China	6	395 0.6×	464 1.9×	136 0.8×	70 0.6×	151 2.0×	9	822
S E Litwin United States	10	807 1.2×	211 0.8×	117 0.7×	46 0.4×	188 2.5×	12	981
Frank Diet Germany	11	566 0.8×	364 1.5×	149 0.8×	38 0.3×	172 2.3×	18	872
Daiji Miura Japan	21	838 1.2×	547 2.2×	117 0.7×	40 0.4×	131 1.7×	46	1.3k
Masakatsu Wakeno Japan	13	409 0.6×	436 1.7×	116 0.7×	58 0.5×	146 1.9×	13	1.0k
Violaine Griol‐Charhbili France	11	274 0.4×	220 0.9×	185 1.0×	111 1.0×	90 1.2×	12	520
Kazuhisa Kijima Japan	13	827 1.2×	540 2.2×	331 1.9×	78 0.7×	85 1.1×	17	1.1k
Alexander Reinecke Germany	12	322 0.5×	214 0.9×	117 0.7×	121 1.1×	68 0.9×	30	561

Countries citing papers authored by Omar Nass

Since Specialization

Citations

This map shows the geographic impact of Omar Nass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Nass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Nass more than expected).

Fields of papers citing papers by Omar Nass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Nass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Nass. The network helps show where Omar Nass may publish in the future.

Co-authorship network of co-authors of Omar Nass

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Nass. A scholar is included among the top collaborators of Omar Nass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Nass. Omar Nass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Suzuki, George, Sanjaya Khanal, Sharad Rastogi, et al.. (2007). Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure. Cardiovascular Drugs and Therapy. 21(1). 29–36. 7 indexed citations

Suzuki, George, Takayuki Mishima, Elaine J. Tanhehco, et al.. (2003). Effects of the AT₁‐receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure. British Journal of Pharmacology. 138(2). 301–309. 10 indexed citations

Sabbah, Hani N., Margaret P. Chandler, Takayuki Mishima, et al.. (2002). Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. Journal of Cardiac Failure. 8(6). 416–422. 108 indexed citations

Nass, Omar, Xiao-Ping Yang, Oscar A. Carretero, et al.. (2002). Effects of pre-existing left ventricular hypertrophy on ventricular dysfunction and remodeling following myocardial infarction in rats. The Journal of Heart and Lung Transplantation. 21(10). 1113–1119. 4 indexed citations

Sabbah, Hani N., Walid Haddad, Yuval Mika, et al.. (2001). Cardiac Contractility Modulation With the Impulse Dynamics Signal: Studies in Dogs With Chronic Heart Failure. Heart Failure Reviews. 6(1). 45–53. 36 indexed citations

Stanley, William C., Takayuki Mishima, Gen Suzuki, et al.. (2000). Ranolazine, a Partial Fatty Acid Oxidation (pFOX) Inhibitor, Improves Left Ventricular Performance in Dogs with Chronic Heart Failure. European Journal of Heart Failure. 2(S1). 97–97. 2 indexed citations

Chaudhry, Pervaiz A., Takayuki Mishima, George Suzuki, et al.. (2000). Acute ventricular reduction with the acorn cardiac support device prevents progressive left ventricular dysfunction and remodeling in dogs with advanced heart failure. Journal of the American College of Surgeons. 191(4). S75–S76. 2 indexed citations

Y, Liu, Xiaoping Yang, Victor G. Sharov, et al.. (1997). Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.. Journal of Clinical Investigation. 99(8). 1926–1935. 513 indexed citations breakdown →

Yang, Xiaoping, et al.. (1997). Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. American Journal of Physiology-Heart and Circulatory Physiology. 272(2). H722–H727. 98 indexed citations

10.

Nass, Omar, Howard Rosman, Hisashi Shimoyama, et al.. (1995). Relation of left ventricular chamber shape in patients with low (≤40%) ejection fraction to severity of functional mitral regurgitation. The American Journal of Cardiology. 76(5). 402–404. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact